Skin conditions (dermatitis, eczema, psoriasis) decisions — 2012

The Veteran's claims for increased ratings and service connection were denied. The Board found that the evidence did not meet the criteria for a higher rating or service connection, except for reopening of his PTSD claim.

The Board has determined that the Veteran's migraine headaches and eczema are as a result of her period of active duty service, resolving all reasonable doubt in favor of the Veteran.

The Veteran's appeal is being remanded for a Travel Board hearing. The claims of entitlement to service connection and a compensable rating are not addressed as the appeal is in process.

The Board has determined that additional development is necessary to properly adjudicate the Veteran's claim for a higher rating for his service-connected tinea corporis and epidermophytosis of the feet. The case is being remanded to obtain updated VA treatment records, private medical records from Alliant Techsystems and the Radford Army Ammunition Plant, and an examination to determine the current level of severity of the Veteran's skin disorder.

The Veteran's appeal is being remanded for additional development, including obtaining VA treatment records and scheduling a VA examination to assess the current severity of his acne vulgaris.

The Board has determined that the Veteran's dyshidrotic eczema had its onset in service or is otherwise etiologically related to skin problems presented during his active service, and thus grants service connection for this condition.

The Veteran's atopic eczema is currently rated as 10 percent disabling, and his allergic rhinitis does not meet the criteria for a compensable disability evaluation.

The Board found that the Veteran's death was not caused by a service-connected disability, and thus denied the claim for service connection for the cause of his death.

Your claims for service connection have been remanded to the RO. You will need to provide additional evidence and complete any necessary steps to perfect your appeal of the downstream claim for a higher initial rating for your low back disorder.

The Veteran's appeal has been withdrawn by the appellant prior to a decision being made.

The Veteran's appeal is remanded for a more contemporaneous VA examination to assess the severity of his service-connected tinea dermatitis, including its impact on his lower extremities and hands. Additional medical records should also be obtained.

The Veteran withdrew his appeals on all issues related to chloracne or acneform disease, hepatitis C and the application to reopen the claim of service connection for passive-aggressive personality disorder. The appeal regarding a rating higher than 50 percent for posttraumatic stress disorder was also dismissed as he limited his appeal to a 50 percent rating.

The Veteran's service-connected disabilities render him unable to secure and follow a substantially gainful occupation consistent with his education and occupational experience, effective December 6, 2011.

The Veteran's skin disorders, including chloracne and a skin rash, are presumed to be related to his in-service herbicide exposure. However, the bilateral upper extremity peripheral neuropathy is not presumptively service-connected due to Agent Orange exposure.,The Veteran's current skin conditions do not appear to be directly related to his military service.

The Board has determined that the Veteran's dermatitis of the face and scalp is not service-connected, as it was not incurred or aggravated by his active duty service. The evidence does not support a finding of direct service connection.

The Veteran's Type II diabetes mellitus requires insulin and a restricted diet, but not regulation of activities. The Veteran is unable to secure or follow a substantially gainful occupation by reason of service-connected disabilities.

The Veteran's chronic acne vulgaris with scarring of the trunk and face have been granted higher initial ratings, effective from February 17, 2011.

The Veteran's appeal for reductions in the evaluations of her allergic rhinitis and eczema was dismissed due to a withdrawal request.

The Veteran's claim for an increased rating for his service-connected PFB was denied. The evidence showed that the condition involved less than 20 percent of exposed areas affected and did not require systemic therapy such as corticosteroids or other immunosuppressive drugs during a 12-month period.

The Veteran withdrew his appeal for an initial compensable rating for chloracne before the Board could make a decision.